Referências

Adams, Samuel Hopkins. 1905. The Great American Fraud: a series of articles on the patent medicine evil, reprinted from Collier’s Weekly. Project Gutenberg, eBook nº 44325. https://www.gutenberg.org/ebooks/44325.

Agência Nacional de Vigilância Sanitária. 2026a. Dados abertos: medicamentos registrados no Brasil. https://dados.anvisa.gov.br/dados/DADOS_ABERTOS_MEDICAMENTOS.csv.

Agência Nacional de Vigilância Sanitária. 2026b. Resolução da Diretoria Colegiada RDC nº 1.036, de 9 de julho de 2026: atualização do Anexo I da Portaria SVS/MS nº 344/1998. https://www.gov.br/anvisa/pt-br/assuntos/medicamentos/controlados/lista-substancias.

Agnew-Blais, Jessica C., Guilherme V. Polanczyk, Andrea Danese, Jasmin Wertz, Terrie E. Moffitt, e Louise Arseneault. 2016. “Evaluation of the Persistence, Remission, and Emergence of Attention-Deficit/Hyperactivity Disorder in Young Adulthood”. JAMA Psychiatry 73 (7): 713–20. https://doi.org/10.1001/jamapsychiatry.2016.0465.

American Psychiatric Association. 2013. Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5). American Psychiatric Association. https://doi.org/10.1176/appi.books.9780890425596.

American Psychiatric Association. 2022. Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, Text Revision (DSM-5-TR). American Psychiatric Association Publishing. https://doi.org/10.1176/appi.books.9780890425787.

Ashinoff, Brandon K., e Ahmad Abu-Akel. 2021. “Hyperfocus: the forgotten frontier of attention”. Psychological Research 85 (1): 1–19. https://doi.org/10.1007/s00426-019-01245-8.

Barkley, Russell A. 1997. “Behavioral inhibition, sustained attention, and executive functions: constructing a unifying theory of ADHD”. Psychological Bulletin 121 (1): 65–94. https://doi.org/10.1037/0033-2909.121.1.65.

Barkley, Russell A. et al. 2002. “International Consensus Statement on ADHD: January 2002”. Clinical Child and Family Psychology Review 5 (2): 89–111. https://doi.org/10.1023/A:1017494719205.

Barros, Denise Borges. 2014. “Os usos e sentidos do metilfenidato: experiências entre o tratamento e o aprimoramento da atenção”. Tese (Doutorado em Saúde Coletiva), Instituto de Medicina Social, Universidade do Estado do Rio de Janeiro. http://www.bdtd.uerj.br/handle/1/4724.

Benson, Kari, Kate Flory, Kathryn L. Humphreys, e Steve S. Lee. 2015. “Misuse of stimulant medication among college students: a comprehensive review and meta-analysis”. Clinical Child and Family Psychology Review 18 (1): 50–76. https://doi.org/10.1007/s10567-014-0177-z.

Bradley, Charles. 1937. “The behavior of children receiving Benzedrine”. American Journal of Psychiatry 94 (3): 577–85. https://doi.org/10.1176/ajp.94.3.577.

Brasil. Ministério da Saúde. Secretaria de Vigilância Sanitária. 1998. Portaria nº 344, de 12 de maio de 1998: aprova o Regulamento Técnico sobre substâncias e medicamentos sujeitos a controle especial. Texto republicado no Diário Oficial da União de 1º de fevereiro de 1999. https://bvsms.saude.gov.br/bvs/saudelegis/svs/1998/prt0344_12_05_1998_rep.html.

Bymaster, Frank P., Jason S. Katner, David L. Nelson, et al. 2002. “Atomoxetine increases extracellular levels of norepinephrine and dopamine in prefrontal cortex of rat: a potential mechanism for efficacy in attention deficit/hyperactivity disorder”. Neuropsychopharmacology 27 (5): 699–711. https://doi.org/10.1016/S0893-133X(02)00346-9.

Caye, Arthur, Thiago Botter-Maio Rocha, Luciana Anselmi, et al. 2016. “Attention-Deficit/Hyperactivity Disorder Trajectories From Childhood to Young Adulthood: Evidence From a Birth Cohort Supporting a Late-Onset Syndrome”. JAMA Psychiatry 73 (7): 705–12. https://doi.org/10.1001/jamapsychiatry.2016.0383.

Cherry, E. Colin. 1953. “Some experiments on the recognition of speech, with one and with two ears”. The Journal of the Acoustical Society of America 25 (5): 975–79. https://doi.org/10.1121/1.1907229.

Clements, S. D., e J. E. Peters. 1962. “Minimal brain dysfunctions in the school-age child: diagnosis and treatment”. Archives of General Psychiatry 6 (3): 185–97. https://doi.org/10.1001/archpsyc.1962.01710210001001.

Conners, C. K., e L. Eisenberg. 1963. “The effects of methylphenidate on symptomatology and learning in disturbed children”. American Journal of Psychiatry 120: 458–64. https://doi.org/10.1176/ajp.120.5.458.

Cooper, Miriam, Gemma Hammerton, Stephan Collishaw, et al. 2018. “Investigating late-onset ADHD: a population cohort investigation”. Journal of Child Psychology and Psychiatry 59 (10): 1105–13. https://doi.org/10.1111/jcpp.12911.

Crichton, Alexander. 2008. “An inquiry into the nature and origin of mental derangement: on attention and its diseases”. Journal of Attention Disorders 12 (3): 200–204. https://doi.org/10.1177/1087054708315137.

Crowe, Simon F., e Elizabeth K. Stranks. 2018. “The residual medium and long-term cognitive effects of benzodiazepine use: an updated meta-analysis”. Archives of Clinical Neuropsychology 33 (7): 901–11. https://doi.org/10.1093/arclin/acx120.

Csikszentmihalyi, Mihaly. 1975. Beyond Boredom and Anxiety. Jossey-Bass.

Csikszentmihalyi, Mihaly. 2014. “Attention and the Holistic Approach to Behavior”. Em Flow and the Foundations of Positive Psychology. Springer Netherlands. https://doi.org/10.1007/978-94-017-9088-8_1.

Curcio, Christine A., e Kimberly A. Allen. 1990. “Topography of ganglion cells in human retina”. The Journal of Comparative Neurology 300 (1): 5–25. https://doi.org/10.1002/cne.903000103.

Curcio, Christine A., Kenneth R. Sloan, Robert E. Kalina, e Anita E. Hendrickson. 1990. “Human photoreceptor topography”. The Journal of Comparative Neurology 292 (4): 497–523. https://doi.org/10.1002/cne.902920402.

Dalgalarrondo, Paulo. 2019. Psicopatologia e semiologia dos transtornos mentais. 3º ed. Artmed.

DATASUS. s. d. CID-10: F90–F98 Transtornos do comportamento e transtornos emocionais que aparecem habitualmente durante a infância ou a adolescência. CID-10, versão 2008, no site do DATASUS. Acesso em 30 de setembro de 2026. http://www2.datasus.gov.br/cid10/V2008/WebHelp/f90_f98.htm.

Demontis, Ditte, G. Bragi Walters, Georgios Athanasiadis, et al. 2023. “Genome-wide analyses of ADHD identify 27 risk loci, refine the genetic architecture and implicate several cognitive domains”. Nature Genetics 55 (2): 198–208. https://doi.org/10.1038/s41588-022-01285-8.

Demontis, Ditte, Raymond K. Walters, Joanna Martin, et al. 2019. “Discovery of the first genome-wide significant risk loci for attention deficit/hyperactivity disorder”. Nature Genetics 51 (1): 63–75. https://doi.org/10.1038/s41588-018-0269-7.

Faraone, Stephen V. 2018. “The pharmacology of amphetamine and methylphenidate: relevance to the neurobiology of attention-deficit/hyperactivity disorder and other psychiatric comorbidities”. Neuroscience and Biobehavioral Reviews 87: 255–70. https://doi.org/10.1016/j.neubiorev.2018.02.001.

Faraone, Stephen V., Tobias Banaschewski, David Coghill, et al. 2021. “The World Federation of ADHD International Consensus Statement: 208 evidence-based conclusions about the disorder”. Neuroscience & Biobehavioral Reviews 128: 789–818. https://doi.org/10.1016/j.neubiorev.2021.01.022.

Faraone, Stephen V., Joseph Biederman, e Eric Mick. 2006. “The age-dependent decline of attention deficit hyperactivity disorder: a meta-analysis of follow-up studies”. Psychological Medicine 36 (2): 159–65. https://doi.org/10.1017/S003329170500471X.

Finger, Guilherme, Emerson Rodrigues da Silva, e Asdrubal Falavigna. 2013. “Use of methylphenidate among medical students: a systematic review”. Revista da Associação Médica Brasileira 59 (3): 285–89. https://doi.org/10.1016/j.ramb.2012.10.007.

Greely, Henry, Barbara Sahakian, John Harris, et al. 2008. “Towards responsible use of cognitive-enhancing drugs by the healthy”. Nature 456 (7223): 702–5. https://doi.org/10.1038/456702a.

Harpin, V. A. 2005. “The effect of ADHD on the life of an individual, their family, and community from preschool to adult life”. Archives of Disease in Childhood 90 (Suppl 1): i2–7. https://doi.org/10.1136/adc.2004.059006.

James, William. 1890. The Principles of Psychology. V. 1. Henry Holt; Company. https://archive.org/details/principlesofpsyc001jame.

Kendell, R. E., J. E. Cooper, A. J. Gourlay, J. R. Copeland, L. Sharpe, e B. J. Gurland. 1971. “Diagnostic criteria of American and British psychiatrists”. Archives of General Psychiatry 25 (2): 123–30. https://doi.org/10.1001/archpsyc.1971.01750140027006.

Kessler, Ronald C., Lenard Adler, Minnie Ames, et al. 2005. “The World Health Organization Adult ADHD Self-Report Scale (ASRS): a short screening scale for use in the general population”. Psychological Medicine 35 (2): 245–56. https://doi.org/10.1017/S0033291704002892.

Klayman, Alison. 2018. Take Your Pills. Documentário, Netflix, 16 de março de 2018. https://media.netflix.com/en/only-on-netflix/80117831.

Kollins, Scott H., Denton J. DeLoss, Elena Cañadas, et al. 2020. “A novel digital intervention for actively reducing severity of paediatric ADHD (STARS-ADHD): a randomised controlled trial”. The Lancet Digital Health 2 (4): e168–78. https://doi.org/10.1016/S2589-7500(20)30017-0.

Kramer, Franz, e Hans Pollnow. 1932. “Über eine hyperkinetische Erkrankung im Kindesalter”. Monatsschrift für Psychiatrie und Neurologie 82 (1–2): 1–40. https://doi.org/10.1159/000164073.

Lange, Klaus W., Susanne Reichl, Katharina M. Lange, Lara Tucha, e Oliver Tucha. 2010. “The history of attention deficit hyperactivity disorder”. ADHD Attention Deficit and Hyperactivity Disorders 2 (4): 241–55. https://doi.org/10.1007/s12402-010-0045-8.

Laufer, M. W., E. Denhoff, e G. Solomons. 1957. “Hyperkinetic impulse disorder in children’s behavior problems”. Psychosomatic Medicine 19 (1): 38–49. https://doi.org/10.1097/00006842-195701000-00005.

Lim, Julian, e David F. Dinges. 2010. “A meta-analysis of the impact of short-term sleep deprivation on cognitive variables”. Psychological Bulletin 136 (3): 375–89. https://doi.org/10.1037/a0018883.

Maier, Alexander, e Naotsugu Tsuchiya. 2021. “Growing evidence for separate neural mechanisms for attention and consciousness”. Attention, Perception, & Psychophysics 83 (2): 558–76. https://doi.org/10.3758/s13414-020-02146-4.

Mattos, Paulo, Daniel Segenreich, Eloísa Saboya, Mário Louzã, Gabriela Dias, e Marcos Romano. 2006. “Adaptação transcultural para o português da escala Adult Self-Report Scale para avaliação do transtorno de déficit de atenção/hiperatividade (TDAH) em adultos”. Archives of Clinical Psychiatry (São Paulo) 33 (4): 188–94. https://doi.org/10.1590/S0101-60832006000400004.

Mattos, Paulo, Maria Antonia Serra-Pinheiro, Luis Augusto Rohde, e Diana Pinto. 2006. “Apresentação de uma versão em português para uso no Brasil do instrumento MTA-SNAP-IV de avaliação de sintomas de transtorno do déficit de atenção/hiperatividade e sintomas de transtorno desafiador e de oposição”. Revista de Psiquiatria do Rio Grande do Sul 28 (3): 290–97. https://doi.org/10.1590/S0101-81082006000300008.

Mayes, Rick, e Adam Rafalovich. 2007. “Suffer the restless children: the evolution of ADHD and paediatric stimulant use, 1900–80”. History of Psychiatry 18 (72 Pt 4): 435–57. https://doi.org/10.1177/0957154X06075782.

Miller, George A. 1956. “The magical number seven, plus or minus two: some limits on our capacity for processing information”. Psychological Review 63 (2): 81–97. https://doi.org/10.1037/h0043158.

Moffitt, Terrie E., Renate Houts, Philip Asherson, et al. 2015. “Is Adult ADHD a Childhood-Onset Neurodevelopmental Disorder? Evidence From a Four-Decade Longitudinal Cohort Study”. American Journal of Psychiatry 172 (10): 967–77. https://doi.org/10.1176/appi.ajp.2015.14101266.

Morton, W. Alexander, e Gwendolyn G. Stockton. 2000. “Methylphenidate abuse and psychiatric side effects”. Primary Care Companion to the Journal of Clinical Psychiatry 2 (5): 159–64. https://doi.org/10.4088/pcc.v02n0502.

National Center for Health Statistics. 2011. ICD-9-CM Tabular List of Diseases, FY2012. https://ftp.cdc.gov/pub/Health_Statistics/NCHS/Publications/ICD9-CM/2011/.

Paelecke-Habermann, Yvonne, Johannes Pohl, e Bernd Leplow. 2005. “Attention and executive functions in remitted major depression patients”. Journal of Affective Disorders 89 (1–3): 125–35. https://doi.org/10.1016/j.jad.2005.09.006.

Panizzon, Leandro. 1944. “La preparazione di piridil- e piperidil-arilacetonitrili e di alcuni prodotti di trasformazione (Parte Iª)”. Helvetica Chimica Acta 27 (1): 1748–56. https://doi.org/10.1002/hlca.194402701222.

Pennick, Michael. 2010. “Absorption of lisdexamfetamine dimesylate and its enzymatic conversion to d-amphetamine”. Neuropsychiatric Disease and Treatment 6: 317–27. https://doi.org/10.2147/ndt.s9749.

Polanczyk, Guilherme V., Erik G. Willcutt, Giovanni A. Salum, Christian Kieling, e Luis A. Rohde. 2014. “ADHD prevalence estimates across three decades: an updated systematic review and meta-regression analysis”. International Journal of Epidemiology 43 (2): 434–42. https://doi.org/10.1093/ije/dyt261.

Polanczyk, Guilherme, Avshalom Caspi, Renate Houts, Scott H. Kollins, Luis Augusto Rohde, e Terrie E. Moffitt. 2010. “Implications of extending the ADHD age-of-onset criterion to age 12: results from a prospectively studied birth cohort”. Journal of the American Academy of Child and Adolescent Psychiatry 49 (3): 210–16.

Ra, Chaelin K., Junhan Cho, Matthew D. Stone, et al. 2018. “Association of digital media use with subsequent symptoms of attention-deficit/hyperactivity disorder among adolescents”. JAMA 320 (3): 255–63. https://doi.org/10.1001/jama.2018.8931.

Sharman, Johannah, e Michael Pennick. 2014. “Lisdexamfetamine prodrug activation by peptidase-mediated hydrolysis in the cytosol of red blood cells”. Neuropsychiatric Disease and Treatment 10: 2275–80. https://doi.org/10.2147/NDT.S70382.

Simons, Daniel. 2010. Selective attention test. Vídeo no YouTube, canal de Daniel Simons, 10 de março de 2010. https://www.youtube.com/watch?v=vJG698U2Mvo.

Simons, Daniel J., e Christopher F. Chabris. 1999. “Gorillas in our midst: sustained inattentional blindness for dynamic events”. Perception 28 (9): 1059–74. https://doi.org/10.1068/p281059.

Sims, Andrew. 2001. Sintomas da mente: introdução à psicopatologia descritiva. Artmed.

Still, George Frederic. 1902a. “The Goulstonian lectures on some abnormal psychical conditions in children”. The Lancet 159 (4102): 1008–13. https://doi.org/10.1016/S0140-6736(01)74984-7.

Still, George Frederic. 1902b. “The Goulstonian lectures on some abnormal psychical conditions in children”. The Lancet 159 (4103): 1077–82. https://doi.org/10.1016/S0140-6736(01)70022-0.

Still, George Frederic. 1902c. “The Goulstonian lectures on some abnormal psychical conditions in children”. The Lancet 159 (4104): 1163–68. https://doi.org/10.1016/S0140-6736(01)74901-X.

Strohl, Madeleine P. 2011. “Bradley’s Benzedrine studies on children with behavioral disorders”. The Yale Journal of Biology and Medicine 84 (1): 27–33.

Stroop, J. R. 1935. “Studies of interference in serial verbal reactions”. Journal of Experimental Psychology 18 (6): 643–62. https://doi.org/10.1037/h0054651.

Thomas, Rae, Sharon Sanders, Jenny Doust, Elaine Beller, e Paul Glasziou. 2015. “Prevalence of attention-deficit/hyperactivity disorder: a systematic review and meta-analysis”. Pediatrics 135 (4): e994–1001. https://doi.org/10.1542/peds.2014-3482.

Thome, Johannes, e Kerrin A. Jacobs. 2004. “Attention deficit hyperactivity disorder (ADHD) in a 19th century children’s book”. European Psychiatry 19 (5): 303–6. https://doi.org/10.1016/j.eurpsy.2004.05.004.

Timimi, Sami, e Eric Taylor. 2004. “ADHD is best understood as a cultural construct”. The British Journal of Psychiatry 184 (1): 8–9. https://doi.org/10.1192/bjp.184.1.8.

United States Congress. 1906. An Act For preventing the manufacture, sale, or transportation of adulterated or misbranded or poisonous or deleterious foods, drugs, medicines, and liquors, and for regulating traffic therein, and for other purposes. Public, No. 384; 34 Stat. 768–772; aprovado em 30 de junho de 1906. https://www.govinfo.gov/content/pkg/STATUTE-34/pdf/STATUTE-34-Pg768.pdf.

U.S. Food and Drug Administration. 2019. Part I: The 1906 Food and Drugs Act and Its Enforcement. Página de história da FDA. https://www.fda.gov/about-fda/changes-science-law-and-regulatory-authorities/part-i-1906-food-and-drugs-act-and-its-enforcement.

U.S. Food and Drug Administration. 2020a. De Novo classification request DEN200026: EndeavorRx. Carta de decisão, 15 de junho de 2020. https://www.accessdata.fda.gov/cdrh_docs/pdf20/DEN200026.pdf.

U.S. Food and Drug Administration. 2020b. FDA permits marketing of first game-based digital therapeutic to improve attention function in children with ADHD. Comunicado de imprensa, 15 de junho de 2020. http://web.archive.org/web/20250521055652/https://www.fda.gov/news-events/press-announcements/fda-permits-marketing-first-game-based-digital-therapeutic-improve-attention-function-children-adhd.

U.S. Food and Drug Administration. 2023. FDA updating warnings to improve safe use of prescription stimulants used to treat ADHD and other conditions. Drug Safety Communication, 11 de maio de 2023. https://www.fda.gov/drugs/drug-safety-and-availability/fda-updating-warnings-improve-safe-use-prescription-stimulants-used-treat-adhd-and-other-conditions.

Visser, Susanna N., Melissa L. Danielson, Rebecca H. Bitsko, et al. 2014. “Trends in the parent-report of health care provider-diagnosed and medicated attention-deficit/hyperactivity disorder: United States, 2003–2011”. Journal of the American Academy of Child and Adolescent Psychiatry 53 (1): 34–46.e2. https://doi.org/10.1016/j.jaac.2013.09.001.

Westbrook, A., R. van den Bosch, J. I. Määttä, et al. 2020. “Dopamine promotes cognitive effort by biasing the benefits versus costs of cognitive work”. Science 367 (6484): 1362–66. https://doi.org/10.1126/science.aaz5891.

Woods, David L., Mark M. Kishiyama, E. William Yund, et al. 2011. “Improving digit span assessment of short-term verbal memory”. Journal of Clinical and Experimental Neuropsychology 33 (1): 101–11. https://doi.org/10.1080/13803395.2010.493149.

World Health Organization. 1967. Manual of the International Statistical Classification of Diseases, Injuries, and Causes of Death: based on the recommendations of the Eighth Revision Conference, 1965, and adopted by the Nineteenth World Health Assembly. World Health Organization. https://iris.who.int/handle/10665/70934.

World Health Organization. 1977. Manual of the International Statistical Classification of Diseases, Injuries, and Causes of Death: based on the recommendations of the Ninth Revision Conference, 1975, and adopted by the Twenty-ninth World Health Assembly. Volume 1. World Health Organization. https://iris.who.int/handle/10665/40492.

World Health Organization. 2019a. International Classification of Diseases, 11th Revision (ICD-11): 6A05 Attention deficit hyperactivity disorder. ICD-11 for Mortality and Morbidity Statistics. https://icd.who.int/browse/2024-01/mms/en#821852937.

World Health Organization. 2019b. International Statistical Classification of Diseases and Related Health Problems, 10th Revision. Volume 2: Instruction manual. 6º ed. World Health Organization. https://icd.who.int/browse10/Content/statichtml/ICD10Volume2_en_2019.pdf.

World Health Organization. 2022. ICD-11 2022 release. Notícia da OMS, 11 de fevereiro de 2022. https://www.who.int/news/item/11-02-2022-icd-11-2022-release.

World Health Organization. 2024. Clinical descriptions and diagnostic requirements for ICD-11 mental, behavioural and neurodevelopmental disorders. World Health Organization. https://www.who.int/publications/i/item/9789240077263.

World Health Organization. s. d. International Classification of Diseases (ICD): ICD revisions under the auspices of WHO. Página da OMS. Acesso em 30 de setembro de 2026. https://www.who.int/standards/classifications/classification-of-diseases.

Xu, Guifeng, Lane Strathearn, Buyun Liu, Binrang Yang, e Wei Bao. 2018. “Twenty-Year Trends in Diagnosed Attention-Deficit/Hyperactivity Disorder Among US Children and Adolescents, 1997–2016”. JAMA Network Open 1 (4): e181471. https://doi.org/10.1001/jamanetworkopen.2018.1471.